(Q50655379)

English

A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting.

scientific article published on 11 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting. (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

George Dranitsaris

1

object named as

G Dranitsaris

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

author name string

N Beegle

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

T Kalberer

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

S Blau

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

D Cox

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

C Faria

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

publication date

11 March 2014

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

Journal of Oncology Pharmacy Practice

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

21

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

170-177

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

Eribulin mesylate for the treatment of patients with refractory metastatic breast cancer: use of a "physician's choice" control arm in a randomized approval trial

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature

1 reference

https://api.crossref.org/works/10.1177%2F1078155214525369

21 January 2018

Identifiers

10.1177/1078155214525369

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

release_ka2uzhb2vbabtirfvkkzm6tsxa

1 reference

https://api.fatcat.wiki/v0/release/ka2uzhb2vbabtirfvkkzm6tsxa

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24620009

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50655379&oldid=1844695138"